Results 121 to 130 of about 24,413 (256)
Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies
Transfusion, EarlyView.
Eric A. Gehrie, Kevin J. Land
wiley +1 more source
ABSTRACT Objectives This study investigates the expansion of CAR T‐cells and its association to treatment outcome. Methods Patients with aggressive B‐cell lymphomas treated with anti‐CD19 CAR T‐cell therapy axicabtagene ciloleucel (axi‐cel) at Skåne and Sahlgrenska University Hospitals from 2019 to October 2024 were included.
Louise Olsson Werne +6 more
wiley +1 more source
Intraoperative autologous blood transfusion: a systematic review of the literature
Bleeding of the main health problems is intraoperative in hospitals, mainly. Control of adequate oxygen is essential for tissue oxygen. Autologous blood transfusion is used as a strategy to reduce the possibility of negative effects of allo transfusion ...
Chaves, Bárbara Veloso de Ávila +7 more
core
ABSTRACT Aims To describe patients' and oncology nurses' experiences with symptom management care, and influential barriers and facilitators to enhancing evidence‐informed symptom management in an outpatient malignant hematology unit. Design A qualitative descriptive study embedded within an experience‐based co‐design approach.
Kylie Teggart +6 more
wiley +1 more source
Autologous Blood Transfusion in Elective Orthopaedic Surgery
Autologous blood transfusion is one of the most effective ways of avoiding the need for homologous transfusion and all its associated complications.
S E James, M A Smith
core +1 more source
ABSTRACT Background Transfusion‐related iron overload (TRIO) is a late effect of therapy impacting survivors of childhood cancer and hematopoietic stem cell transplantation (HSCT) who receive frequent packed red blood cell (pRBC) transfusions. Surprisingly, there are no accepted guidelines to assist providers in identifying and treating at‐risk ...
Luke Gingell +3 more
wiley +1 more source
Background. The presentation of autologous blood donation with analysis of used blood and the percentage of autologous blood on Orthopedic Department in the years 1996–2000.Methods.
Janka Černe-Zavadlav +2 more
doaj
Activation of the complement system by different autologous transfusion devices: an in vitro study
BACKGROUND: The aim of the present investigation was to study whether autologous transfusion devices activate the complement system and whether complement-activated blood is more vulnerable to further activation during processing.
Bengtson, Jan Peter, +2 more
core
To evaluate the safety and effectiveness of the intraoperative phlebotomy with acute hemodilution and autologous transfusion as an approach to blood conservation during cardiac operation, 126 patients were grouped into autologous transfusion group(Group ...
곽영란
core +1 more source
Clinical efficacy of a novel autologous blood recovery device during ECMO weaning
[Objective] To evaluate the clinical efficacy of a novel autologous blood recovery device during the weaning process from extracorporeal membrane oxygenation (ECMO).
LU Yufeng +5 more
doaj +1 more source

